Accessibility Menu
 
NextCure logo

NextCure

(NASDAQ) NXTC

Current Price$10.39
Market Cap$35.57M
Since IPO (2019)-96%
5 Year-93%
1 Year+36%
1 Month-24%

NextCure Financials at a Glance

Market Cap

$35.57M

Revenue (TTM)

$0.00

Net Income (TTM)

$55.84M

EPS (TTM)

$-21.91

P/E Ratio

-0.46

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Price

$10.39

Volume

1,531

Open

$10.11

Previous Close

$10.39

Daily Range

$9.93 - $10.39

52-Week Range

$2.69 - $15.74

NXTC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NextCure

Industry

Biotechnology

Employees

40

CEO

Michael S. Richman

Headquarters

Beltsville, MD 20705, US

NXTC Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-111%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-2.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$35.57M

Shares Outstanding

3.56M

Volume

1.53K

Short Interest

0.00%

Avg. Volume

34.74K

Financials (TTM)

Gross Profit

$2.19M

Operating Income

$57.62M

EBITDA

$55.43M

Operating Cash Flow

$49.61M

Capital Expenditure

$0.00

Free Cash Flow

$49.61M

Cash & ST Invst.

$41.82M

Total Debt

$4.15M

NextCure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$365.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$35.57M

N/A

Market Cap/Employee

$827.17K

N/A

Employees

43

N/A

Net Income

$9.44M

+18.7%

EBITDA

$9.39M

+20.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$36.66M

-41.5%

Accounts Receivable

$100.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.15M

-19.5%

Short Term Debt

$1.00M

+26.3%

Return on Assets

-1.11%

N/A

Return on Invested Capital

-1.45%

N/A

Free Cash Flow

$7.64M

-10.1%

Operating Cash Flow

$7.64M

-9.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BOLDBoundless Bio, Inc.
$1.19+3.48%
PLURPluri Inc.
$3.11-0.64%
TAOXTAO Synergies Inc.
$5.95+5.50%
JSPRJasper Therapeutics, Inc.
$1.23+0.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About NXTC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.